Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.

Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.

Many people with psoriasis notice their skin clears up after spending some time in the sun. Others experience irritation, ...

Real-world persistence data for tildrakizumab paint an encouraging picture of long-term treatment durability, with ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...

What happens when something once associated with healing suddenly feels dangerous? A diagnosis can change identity, perception, and daily life.

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...

Biologic-naïve status and higher inflammation predict rapid skin clearance with psoriasis biologics, while palmoplantar ...

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...

Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...